Market Overview

Global Cardiac Rhythm Management Devices Market Segmented by Product Type & Geography - Analysis, Growth, Trends & Forecast 2018-2023, With an Expected CAGR of 4.8% - ResearchAndMarkets.com

Share:

The "Global
Cardiac Rhythm Management Devices Market - Segmented by Product Type and
Geography - Growth, Trends, and Forecast (2018 - 2023)"
report
has been added to ResearchAndMarkets.com's offering.

The global cardiac rhythm management devices market is expected to
register a CAGR of 4.8% during the forecast period, 2018-2023.

The increasing instances of cardiovascular disorders is one of the
foremost factors driving the cardiac rhythm management devices market.
Globally, cardiovascular diseases account for more than 30% deaths,
amounting to 17 million people. Also, nearly 33.5 million people,
globally, are suffering from atrial fibrillation (AFib), which is the
most common type of serious arrhythmia. With the rise in the aging
population in America and Europe, a number of patients suffering heart
rhythm disorders are likely to witness an increase, and this is a cause
for concern.

The therapeutic radiation used in cancer treatment can influence the
operation of a patient with implantable cardiac rhythm devices. The
implantable device technology uses complementary metal-oxide
semiconductor (CMOS) which are vulnerable to damage by the therapeutic
doses of radiation, but it can vary according to the type of device in
use.

North America is expected to have the largest market share for cardiac
rhythm management, due to developed healthcare infrastructure,
government initiatives, rising number of death due to cardiovascular
diseases, and rising incidence of arrhythmias demanding more cardiac
implants. According to a report by the US CDC, more than 75,000
hospitalizations are attributed atrial fibrillation. Also, it
highlighted that a large part of the American population suffers from
atrial fibrillation.

Companies Mentioned

  • Abbott
  • Abiomed
  • Biotronik Se & Co Kg
  • Boston Scientific Corporation
  • Koninklijke Philips Nv
  • Livanova Plc
  • Medtronic Plc
  • Schiller Ag
  • Shenzhen Mindray Biomedical Electronics Co. LTD
  • Zoll Medical Corporation

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Major Players

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/bl97tb/global_cardiac?w=4

View Comments and Join the Discussion!